CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Hubei Joye 3D High-tech Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Hubei Joye 3D High-tech Co Ltd
Phone: +86 2788991133p:+86 2788991133 WUHAN, HUB  China Fax: +86 2788234678f:+86 2788234678

Business Summary
Hubei Joye 3D High-tech Co Ltd is a China-based company mainly engaged in the research and development, manufacuturing and sales of medical materials and three-dimensional (3D) printing customized medical devices. The Company's main products include medical devices, educational equipment, custom dentures, 3D printers, 3D scanners and 3D printer accessories. It also provides educational equipment related services, 3D dental data services and 3D printing services.
(Source: ARS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/201412/31/2014Yes----

General Information
Outstanding Shares: 3,000,000 (As of 12/31/2014)
Fax Number: +86 2788234678


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023